Connect with us

Business

Latest Developments: Frontier Communications Corp (NASDAQ:FTR), New Gold Inc. (USA)(NYSEMKT:NGD), JetBlue Airways Corporation(NASDAQ:JBLU)

Published

on

Frontier Communications Corp (NASDAQ:FTR)’s shares gained 0.35% to $5.79. Crius Energy Trust on July 8 announced that Crius Energy LLC (“Crius Energy”) and Frontier Communications Corporation (“Frontier”) (FTR) have further expanded their strategic marketing partnership to offer natural gas to Frontier residential and commercial customers in California .  The natural gas offering, through FTR Energy Services, one of Crius Energy’s best-in-class energy brands, extends its current energy offerings in California of solar energy products.

Get the Inside Scoop On FTR here with this Free Report

New Gold Inc. (USA)(NYSEMKT:NGD)’s shares jumped 5.18% to $6.50. The company plans to release its second quarter 2014 financial results prior to the market opening on Thursday, July 31, 2014.

You won’t believe what we found out about NGD

Additionally, the company on July 7 announces a mid-year update of the New Afton C-zone mineral resource. The C-zone is a continuation of the New Afton block cave that extends along strike and below the B-zone reserve that is currently being mined. The mid-year update builds upon the 2013 year-end C-zone mineral resource estimate and includes the results of an additional 15,143 metres of drilling in 20 core holes. The updated resource estimate will be used to evaluate the optimum extraction level depth for a potential block cave mining plan for the C-zone that could extend New Afton’s mine life. The June 2014 C-zone Measured and Indicated contained gold resource has increased by 24% and the contained copper resource by 29% when compared to year-end 2013.

JetBlue Airways Corporation(NASDAQ:JBLU)’s shares increased 1.62% to $10.66. The company on July 9 announced the launch of automatic check-in, a technological enhancement that will allow customers to focus on their travel plans and not the need to get to a computer 24 hours before their flight departs to check-in. Automatic check-in is the most recent step in the airline’s continued focus on making the JetBlue Experience even more convenient. This initial technological innovation removes the need for customers to ever have to check-in for their flights.

Why Should You Buy JBLU Now? Get The Free Trend Analysis Here

Business

Top 3 Gainers: Zynga (NASDAQ:ZNGA), Eros International (NYSE:EROS), Borqs Technologies’ (BRQS)

Published

on

By

Zynga (NASDAQ:ZNGA) is up 2.5% after Benchmark reiterated its Buy rating in a look-ahead at Q2 earnings. The firm’s expecting a beat and solid guidance for Q3, and it’s raising its guidance for the fiscal year.

Tailwinds from the pandemic won’t dissipate easily, Benchmark suggests, and the videogame maker’s acquisition of Peak (and with it new “forever franchises” in Toon Blast and Toy Blast) will drive audience, bookings, margins and free cash flow, it says. The firm has an $11 price target, now implying 14% upside.

Eros International (NYSE:EROS) is up 5.8% today, making up the last week’s lost ground, after news that its streaming service Eros Now is partnering with Sony India (SNE +2.3%).

That will mean Eros Now’s app is pre-installed on selected Sony smart televisions in India, along with availability on a large base of existing models (Bravia E series and newer).

The country over the past year has seen a 25% growth in demand for smart TVs, fueled by overall industry growth of 15%, to a record 15M units/year.

Borqs Technologies’ (BRQS) personal safety tracker sees strong market with increased orders from the electronics retail chain in the US.

The boost in product demand comes ahead coronavirus pandemic that provides company to expect delivery of 250K units this year. It reflects over 3x the volume delivered in 2019, the year of its launch.

Borqs’ mobile personal safety devices designed particularly for senior citizens come with panic button, location tracking, and fall detection.

Continue Reading

Biotech

Biotech movers: Pfizer Inc. (PFE), Celgene Corporation (CELG)

Published

on

Pfizer Inc. (PFE) said on Thursday it received a request for documents as part of a U.S. investigation related to quality issues involving the manufacture of auto-injectors at its Meridian Medical Technologies site.

Pfizer, in a regulatory filing, said it would be producing records in response to the civil investigative demand from the U.S. Attorney’s office for the Southern District of New York.

Why ASDN Could Massively Outperform PFE in 2019

Meridian, a unit of Pfizer that manufactures EpiPen injectors used to deliver an emergency allergy antidote, has been hit by a series of manufacturing problems in recent years. Mylan NV, which markets EpiPens, has recalled tens of thousands of the devices after complaints that some had failed to activate.

Bristol-Myers Squibb has been meeting with shareholders in Boston and New York over the last two weeks to try to salvage its $74 billion purchase of cancer drugmaker Celgene Corporation (CELG), the biggest acquisition announced so far this year.

Why Investors Are Calling ASDN the CELG of the Sky!

The deal, announced in January, was hard sell to Bristol shareholders from the start. The acquisition adds about $32 billion in fresh debt to Bristol’s balance sheet while assuming $20 billion in Celgene’s debt, the companies said at the time. After factoring in debt, the acquisition was the largest health-care deal on record, according to data compiled by Refinitiv.

Now, hedge funds Wellington Management and Starboard Value say the deal doesn’t sit well with them. Bristol has sent executives to New York to meet with institutional investors several times over the last two weeks and met with investors in Boston on Wednesday and Thursday, according to a person who briefed on the meetings.

Bristol-Myers declined to comment.

Continue Reading

Biotech

Big Losers: Corbus Pharmaceuticals Holdings, Inc. (CRBP), Petróleo Brasileiro S.A. – Petrobras (PBR)

Published

on

Corbus Pharmaceuticals Holdings, Inc. (CRBP)’s shares slumped as much as 16% to $6.94 on huge volume. The stock has been showing intense sell off suddenly after a bearish article on seekingalph.com by Alpha Exposure.

The article stated that Corbus has ties to investors convicted of or alleged to have committed securities fraud. We believe lenabasum has failed its major trials in SSc and CF. Lenabasum was also denied Breakthrough Therapy Designation in SSc. We believe lenabasum will fail in its pivotal SSc and Phase 2b CF trials. We are short Corbus with a price target of $0.50.

Wow the future of Autonomous flight is finally here with the launch of ASDN passenger drone Elroy

Petróleo Brasileiro S.A. – Petrobras (PBR) is expanding its ambitious divestment program and has “bold” plans for sales, the Brazilian state-run oil company’s chief executive said after the firm posted its first annual profit in five years.

On a conference call with analysts to discuss fourth-quarter results, CEO Roberto Castello Branco said selling non-core assets will be key to deleveraging.

Petrobras, as the company is known, can reduce its ratio of net debt to earnings before interest, taxes, depreciation and amortization, or EBITDA, to 1.5 or even to 1, he added.

The University of Chicago-educated CEO, who took the reins in early January, has long been vocal about the need to slim down the sprawling firm and focus on core activities such as exploration and production. Thursday’s comments were some of his most assertive on the matter.

Why Investors Are Calling ASDN the TPC of the Sky!

Continue Reading
Advertisement

Trending